131 related articles for article (PubMed ID: 579835)
21. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report.
Agnelli G; Gresele P; De Cunto M; Gallai V; Nenci GG
Br J Obstet Gynaecol; 1982 Aug; 89(8):681-2. PubMed ID: 7104262
[TBL] [Abstract][Full Text] [Related]
22. [Copper-7 intrauterine device (Gravigard). Report of experience].
Jürgensen O; Stenzel I; Wirth A; Sina D; Taubert HD
Fortschr Med; 1976 Mar; 94(9):515-21. PubMed ID: 964914
[TBL] [Abstract][Full Text] [Related]
23. Intrauterine devices: present and future.
Guillebaud J
Int J Gynaecol Obstet; 1980; 18(5):325-32. PubMed ID: 6110576
[TBL] [Abstract][Full Text] [Related]
24. Two years' experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study.
Nilsson CG; Allonen H; Diaz J; Luukkainen T
Fertil Steril; 1983 Feb; 39(2):187-92. PubMed ID: 6401636
[TBL] [Abstract][Full Text] [Related]
25. Changes of plasminogen activator in human uterine tissue induced by intrauterine contraceptive devices.
Shaw ST; Macaulay LK; Sun NC; Tanaka MS; Roche PC
Contraception; 1983 Feb; 27(2):131-40. PubMed ID: 6682747
[TBL] [Abstract][Full Text] [Related]
26. [Endometrial histology studied in women bleeding with IUD in situ].
Nesit V; Kyselá T
Cesk Gynekol; 1975 Jul; 40(6):427-31. PubMed ID: 1157133
[TBL] [Abstract][Full Text] [Related]
27. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status.
Milsom I; Andersson K; Jonasson K; Lindstedt G; Rybo G
Contraception; 1995 Sep; 52(3):175-9. PubMed ID: 7587189
[TBL] [Abstract][Full Text] [Related]
28. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
Malmqvist R; Petersohn L; Bengtsson LP
Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
[TBL] [Abstract][Full Text] [Related]
29. A statistical study of the copper T and copper 7 intrauterine devices.
Gupta HD; Gupta I; Devi PK
Contraception; 1976 Dec; 14(6):655-60. PubMed ID: 1017199
[TBL] [Abstract][Full Text] [Related]
30. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
Stanback J; Grimes D
Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
[TBL] [Abstract][Full Text] [Related]
31. [Infection hazards and complications following the use of IUDs].
Böhm W; Seewald HJ; Voigt R; Süss C
Zentralbl Gynakol; 1977; 99(24):1484-8. PubMed ID: 605704
[TBL] [Abstract][Full Text] [Related]
32. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
[TBL] [Abstract][Full Text] [Related]
33. Assessing the intrauterine device.
Mishell DR
Fam Plann Perspect; 1975; 7(3):103-11. PubMed ID: 1140345
[TBL] [Abstract][Full Text] [Related]
34. Clinical study of a progesterone-releasing intrauterine contraceptive device.
Brenner PF; Cooper DL; Mishell DR
Am J Obstet Gynecol; 1975 Mar; 121(5):704-6. PubMed ID: 1115173
[TBL] [Abstract][Full Text] [Related]
35. [Intrauterine contraception in nulliparous women].
Prilepskaia VN; Mezhevitinova EA
Akush Ginekol (Mosk); 1991 Apr; (4):5-8. PubMed ID: 1862876
[TBL] [Abstract][Full Text] [Related]
36. Treatment of increased menstrual blood loss in IUD users.
Toppozada M
Contraception; 1987 Jul; 36(1):145-57. PubMed ID: 3311623
[TBL] [Abstract][Full Text] [Related]
37. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
38. The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices.
Yin M; Zhu P; Luo H; Xu R
Contraception; 1993 Sep; 48(3):245-54. PubMed ID: 8222654
[TBL] [Abstract][Full Text] [Related]
39. Endometrial morphometry in users of intrauterine contraceptive devices and women with ovulatory dysfunctional uterine bleeding: a comparison with normal endometrium.
Wang IY; Russell P; Fraser IS
Contraception; 1995 Apr; 51(4):243-8. PubMed ID: 7796590
[TBL] [Abstract][Full Text] [Related]
40. Hemorrhage induced by intrauterine devices: control by local proteinase inhibition.
Tauber PF; Wolf AS; Herting W; Zaneveld LJ
Fertil Steril; 1977 Dec; 28(12):1375-7. PubMed ID: 590549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
